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BACKGROUND: Data on congenital anomalies from developing countries of the sub-Saharan region are
scarce. However, it is important to have comprehensive and reliable data on the description and prevalence
of congenital anomalies to allow surveillance and the implementation of appropriate public health strategies
for prevention and management. In this study, we describe the proﬁle of congenital anomalies seen in a
birth cohort in Entebbe, Uganda. METHODS: Congenital anomalies were deﬁned as any structural defect
present at birth. Pregnant women were recruited to the cohort between 2003 and 2005. Defects present at
birth were recorded by the midwife at delivery and by physicians at the routine six-week postnatal visit and
at illness-related visits until 1 year of life. The anomalies were classiﬁed by organ system according to the
10th version of the World Health Organization International Classiﬁcation of Diseases (ICD-10). RESULTS:
There were 180 infants with a congenital anomaly among 2365 births. The most commonly affected systems
were the musculoskeletal (42.7 per 1000 births) and skin (16.1 per 1000 births). The prevalence of major
anomalies was 20.3 per 1000 births; 1.7 per 1000 births for cardiac anomalies and 1.3 per 1000 births for neu-
ral system anomalies. Forty (22%) of the congenital anomalies were identiﬁed at birth, 131 (73%) at the 6-
week postnatal visit, and nine (5%) at illness-related visits. CONCLUSION: Congenital anomalies are common
in developing countries. Establishment of comprehensive databases for surveillance would be helpful for
surveillance of effects of new exposures, for prevention, management, and health care planning. Birth
Defects Research (Part A) 91:857–861, 2011.  2011 Wiley-Liss, Inc.
Key words: congenital anomalies; infants; epidemiology; Uganda; Africa
INTRODUCTION
Congenital anomalies are a global problem and every
year an estimated 7.9 million children are born with a
serious birth defect, 3.3 million children under ﬁve years
of age die from birth defects, and 3.2 million who survive
may be disabled for life (Carmona, 2005). While more
than 90% of all infants with a serious congenital anomaly
are born in middle-income and low-income countries,
comprehensive data on congenital anomalies in these
countries are not available.
Reports have noted the very high prevalence of poly-
dactyly in blacks (Simpkiss and Lowe, 1961; Kromberg
and Jenkins, 1982) and of the hemoglobin disorders in
sub-Saharan Africa (World Health Organization, 1996)
but few reports exist on the prevalence of other congeni-
tal anomalies in Africa and it is difﬁcult to compare
reports because of differences in study design, methods
of ascertainment, and nomenclature. The actual preva-
lence of congenital anomalies in Africa may be different
than in the developed world due to differences in genet-
ics and differences in exposures such as infections, while
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underreporting, deﬁciencies in diagnostic capabilities,
and poor follow-up for examination for anomalies in the
postnatal period.
In many developing countries, birth defects registries
are absent and the health care services, from antenatal
through obstetric to postnatal and adolescent health care,
are challenged with fundamental gaps in the understand-
ing, prevention, and treatment of congenital anomalies.
To date, the only report on congenital anomalies in
Uganda is by Simpkiss and Lowe (1961) who described a
prospective study done at the national referral hospital
between 1956 and 1957. Without comprehensive data on
congenital anomalies in this region, it is difﬁcult to evalu-
ate possible teratogens and to institute comprehensive
and effective prevention and care services. For example,
at this time, with the advent of antiretroviral therapy in
pregnant women with HIV/AIDS in Africa, it would be
paramount to monitor any effects of antiretroviral ther-
apy used in pregnancy on the incidence of congenital
anomalies (Watts, 2007). In this cohort, data on congenital
anomalies were collected carefully, and no association
with the trial interventions, albendazole and praziquan-
tel, was found (Ndibazza et al., 2010). Therefore, the
cohort provides an opportunity to describe the frequency
and range of anomalies in a typical African population.
MATERIALS AND METHODS
Study Area
This study was part of an ongoing randomized double-
blind placebo-controlled trial conducted in Entebbe,
Uganda, to determine the effect of helminths and their
treatment in pregnancy and in young children on immu-
nologic and disease outcomes in childhood (Elliott et al.,
2007; Webb et al., 2011). The study area comprises
Entebbe Municipality and Katabi subcounty, on the
Entebbe peninsula in Lake Victoria. The area is occupied
by urban, rural, and ﬁshing communities. The population
is estimated at 70,200 (Uganda Bureau of Statistics, 2007),
and 93% of deliveries in this community are carried out
in health units (Ministry of Health, 2002). The area is
comprised of several tribes; 49% of the pregnant women
were from the indigenous Baganda tribe, with less than
10% from any other individual tribe (Woodburn et al.,
2009).
Study Population
Consecutive pregnant women were recruited at the
Entebbe General Hospital antenatal clinic between April
2003 and November 2005. Women were screened and en-
rolled in their second or third trimester if they were a
resident in the study area, planning to deliver at the hos-
pital, and willing to know their HIV status. Women with
severe anemia (hemoglobin <8 g/dL), severe liver dis-
ease, history of diarrhea with blood in stool, an abnormal
pregnancy, history of adverse reaction to anthelminthics,
or who had been enrolled in the study during an earlier
pregnancy were excluded. No prenatal screening by
ultrasound was carried out.
At enrollment, which was restricted to the second and
third trimester of pregnancy, participants were random-
ized to albendazole or placebo (400 mg; GlaxoSmithKline,
Brentford, United Kingdom), and praziquantel (40 mg
per kilogram; Medochemie Ltd, Limassol, Cyprus) or pla-
cebo, as a single oral dose. All women were offered rou-
tine antenatal care, including hematinics (iron and folate),
and intermittent presumptive treatment for malaria using
sulfadoxine-pyrimethamine. Women were treated for
syphilis if a rapid plasma reagin test was positive, and
those who tested HIV-positive were provided with nevir-
apine (200 mg, single oral dose, to be taken at onset of
labor) for prevention of mother-to-child HIV transmis-
sion.
Written informed consent was obtained from all eligi-
ble women. The study received ethical approval from the
Science and Ethics Committee, Uganda Virus Research
Institute; the Uganda National Council for Science &
Technology; and the London School of Hygiene & Tropi-
cal Medicine.
Congenital anomalies were deﬁned as any structural
defect present at birth. Chromosomal analysis was not
done and diagnoses such as Down’s syndrome were
based on clinical ﬁndings. The midwives carried out an
external examination for overt anomalies, and no speciﬁc
examination routine was followed. Anomalies detected
by the physicians followed a thorough physical examina-
tion, supported when necessary by referral to specialists.
Special investigations such as an echocardiogram were
only done if there was clinical indication. Infants who
had congenital anomalies involving more than one sys-
tem were recorded once as having a multiple congenital
anomaly. When no deﬁnite diagnosis was made, the
infant was classiﬁed and coded as having an unspeciﬁed
congenital anomaly. The anomalies were classiﬁed by
organ system according to the 10th version of the World
Health Organization International Classiﬁcation of Dis-
eases (ICD-10; International Classiﬁcation of Diseases,
2007).
Statistical Analysis
Data were analyzed using Stata version 9 (Stata Corp.,
College Station, TX). The prevalence of congenital
anomalies was deﬁned as the number of individual live
and stillborn infants with a congenital anomaly per 1000
total births. Associations with maternal age and socioeco-
nomic status, child’s sex, multiplicity, and infant mortal-
ity were assessed using the chi-square test and logistic
regression.
RESULTS
The ﬂow of the study was previously reported by Ndi-
bazza et al. (2010). There were 2345 live births and 44
stillbirths; 72% were delivered at Entebbe General Hospi-
tal, 17% at a private health unit, and 11% at home.
Thirty-eight stillbirths (86%) and 2327 live births (99%)
were examined for a congenital anomaly from April 2003
to April 2007; 2115 infants were still under follow-up at
the age of 1 year. The midwives examined infants deliv-
ered at the Entebbe General Hospital; data on ﬁndings at
delivery were not available for infants delivered else-
where. The study physicians examined children for con-
genital anomalies at the six-week postnatal visit or at an
illness visit. Forty congenital anomalies (22%) were iden-
tiﬁed by the midwives at birth, while the physicians
identiﬁed 131 (73%) at the 6-week postnatal visit and
nine (5%) at illness-related visits to the study clinic; an
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of major anomalies was 20.3 per 1000 births; 1.7 per 1000
births for cardiac anomalies and 1.3 per 1000 births for
neural system anomalies. Three of the 38 stillbirths had a
congenital anomaly.
Prevalence rates for the different congenital anomalies
are shown in Table 1. The most commonly affected sys-
tems were the musculoskeletal (42.7 per 1000 births) and
skin (16.1 per 1000 births). Among these, defects of the
abdominal wall musculature were the most common fol-
lowed by polydactyly, which often consisted of postaxial
polydactyly. One of the infants with defects of the skin
had poliosis, while the rest had a birthmark. Only one of
the six infants with defects of the genitourinary system
was female. Three of the four cases with defects of the
cardiovascular system were septal defects, while one had
a patent ductus arteriosus. Of the three infants with
defects of the neural system, one had anencephaly,
another had hydrocephaly, and the third had spina
biﬁda. Of the 10 cases with multiple system defects, ﬁve
had an umbilical hernia with another system defect, four
had a birthmark with another system defect, one had low
set ears, a short neck, and a left lower limb deformity,
while another had ﬂexion deformity of the ﬁngers on
both hands with a macrocephaly and an unspeciﬁed
anomaly of the gastrointestinal tract. One infant had an
unspeciﬁed defect of the upper gastrointestinal tract, and
another infant had an unspeciﬁed anomaly of the respira-
tory system.
The proportion of total anomalies was higher in boys
(8%; 99 of 1224) than in girls (7%; 81 of 1141) but the dif-
ference was not statistically signiﬁcant (p 5 0.4). Multiple
births, maternal age, and socioeconomic status, as well as
maternal HIV were not signiﬁcantly associated with hav-
ing a congenital anomaly. As previously reported, there
was no association between congenital anomalies and the
anthelminthic trial interventions (Ndibazza et al., 2010).
The congenital anomalies identiﬁed among the three
stillbirths were anencephaly, polydactyly, and club foot.
The infant mortality rate was slightly higher among
infants with a congenital anomaly compared to those
without a congenital anomaly (odds ratio 5 1.81; 95%
conﬁdence interval, 0.95–3.46). Hemoglobin disorders are
not reported as these were not systematically screened
for.
DISCUSSION
In our study, we recorded an overall prevalence of
congenital anomalies, detected between birth and age 1
year, of 76 per 1000 births. The rate of major anomalies
was 20.3 per 1000 births. The majority were minor
anomalies with minimal effect on clinical function. In an
earlier, small study based in the Entebbe Hospital mater-
nity ward, Tann et al. (2005) observed a prevalence of
congenital anomalies among neonates of 17 per 1000
births. This much lower ﬁgure accords precisely with our
observation that only 22% of anomalies were identiﬁed
by midwives at birth, and could indicate that detection
of congenital anomalies may well quadruple from birth
to age one year. We observed a slight male preponder-
ance of malformations, similar to ﬁndings elsewhere
(Lary and Paulozzi, 2001; Riley and Halliday, 2008;
Bakare et al., 2009), and in keeping with the ﬁndings of
Lary and Paulozzi (2001), we observed that anomalies of
the genitourinary system were more prevalent among
boys.
We found only one other report on congenital anoma-
lies in Uganda, by Simpkiss and Lowe (1961) who exam-
ined 2068 newborn babies for congenital anomalies at the
Mulago national referral hospital; this reported an inci-
dence rate of 54 per 1000 births. This rate at birth was
higher than ours, which could be a result of more detailed
examination at birth or selection bias considering that
deliveries at the national referral hospital were more likely
high-risk pregnancies. The Simpkiss study, unlike ours,
reported a high prevalence of prehelicine ﬁstulas, how-
ever, similar to our study, they observed very few anoma-
lies of the neural and cardiac systems, and the prevalence
of musculoskeletal system anomalies (excluding umbilical
and inguinal hernias) was comparable.
Not everyone would include umbilical and inguinal
hernias in congenital anomalies. Both the ICD-9 and ICD-
10 classify umbilical and inguinal hernias under ‘Diseases
of the Digestive System (K00-K93)’ and not under ‘Con-
genital malformations, deformations, and chromosomal
abnormalities (Q00-Q99)’. However, in clinical practice,
umbilical and inguinal hernias are often included among
minor congenital anomalies, since they result from the
persistence of a weak area in the abdominal muscles. The
European Surveillance of Congenital Anomalies, a net-
work of population-based registers for the epidemiologic
surveillance of congenital anomalies, also recognizes um-
bilical hernias as congenital anomalies albeit minor ones.
If these anomalies were excluded, the prevalence of mus-
culoskeletal defects in our study population would be 14
per 1000 births. Others have also noted a high prevalence
of anomalies of the musculoskeletal system among black
populations; 10.07 of 1000 compared to 5.59 of 1000
among the Dutch reference group (Anthony et al., 2005),
and 27.4 of 1000 compared to 21.2 of 1000 among the
white group (Christianson et al., 1981). In the same studies,
there were relatively lower rates of neural defects; 2.98 of
1000 compared to 3.06 of 1000 among the Dutch reference
group (Anthony et al., 2005), and 5.4 of 1000 compared to
6.0 of 1000 among the white group (Christianson et al.,
1981). Hence race and ethnicity should be taken into con-
sideration when the prevalence rates of congenital anoma-
lies are compared in different populations.
In this study, all the cardiac and most of the genitouri-
nary defects were detected in infancy by the research
physicians, at the six-week postnatal visit, or at an illness
visit. At birth, the midwives detected the more overt
anomalies of the neural and musculoskeletal systems.
Improvement in the training of midwives in routine ex-
amination of the newborn for congenital anomalies, and
inclusion of this in their routine duties, is likely to be fea-
sible (Williamson et al., 2005) and could particularly
improve the recognition and management of important
anomalies in settings, such as Uganda, where doctor:pa-
tient ratios are very low.
Population-based estimates of the overall prevalence of
congenital anomalies and epidemiologic trends are lack-
ing in many African countries. Therefore, birth prevalen-
ces of congenital anomalies can only be approximated
from hospital-based and community-based data, which
may not necessarily be an accurate representation of the
general population; although 93% of deliveries in this
study area are carried out in health units (Ministry of
Health, 2002), the proportion of births occurring in a
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Bureau of Statistics, 2007). However, in this study, 73%
of the congenital anomalies were identiﬁed at the six-
week postnatal visit, which, according to the national im-
munization schedule, is the ﬁrst postnatal visit to a
health unit and implies that a considerable number of
children born with a birth defect can be identiﬁed at this
visit, providing more comprehensive data on congenital
Table 1
Classiﬁcation of Congenital Anomalies According to the ICD-10
System Number Percentage Detail ICD-10 Anomaly detected at
b
GIT 1 1
aUnspeciﬁed upper GIT obstruction Q 40.9 Illness visit
Genitourinary
system
63 Undescended testis & hypospadias Q 53.9 & 54.9 Birth
Phimosis Q 55.8 Illness visit
Imperforate hymen Q 52.3 6 weeks’ visit
Hydrocele (2) P 83.5 6 weeks’ visit
Small white cyst at base of penis Q 55.8 Birth
Cardiovascular
system
42 Patent ductus ateriosus Q 25.0 Illness visit
VSD Q 21.0 Illness visit
Perimembranous VSD Q 21.0 Illness visit
Atrial-septal defect Q.21.1 Illness visit
Dysmorphic 4 2 Down syndrome Q 90.9 Birth
Facial asymmetry (2) Q 67.0 Birth/6 weeks’visit
Short mandible, short maxilla, and
high arched palate
Q 38.5 6 weeks’ visit
Head & neck 12 7 Small nodular mass, right side of face Q 82.9 Illness visit
Choanal atresia Q 30.0 Illness visit
Ankyloglossia (4) Q 38.1 6 weeks’ visit
Branchial cleft vestige Q 18.0 Birth
Preauricular sinus Q 18.1 6 weeks’ visit
Preauricular tags (2) Q 17.0 6 weeks’ visit
Small growth on tongue Q 38.3 Birth
Growth right side of neck Q 18.9 Illness visit
Multiple systems 10 6 Umbilical hernia & ankyloglossia K 42, Q 38.1 6 weeks’ visit
Inguinal scrotal hernia & birthmark K 40, Q 82.5 6 weeks’ visit
Preauricular sinus & birthmark Q 18.1, Q 82.5 6 weeks’ visit
Umbilical hernia, inguinal hernia &
club foot
K 42, K40, Q 66.0 6 weeks’ visit
Flexion deformity ﬁngers &
microcephaly & unspeciﬁed
abnormality of the GIT
Q 68, Q75.3, Q43 Birth
Umbilical hernia & birthmark (2) K 42, Q 82.5 6 weeks’ visit
Low set ears, short neck & left limb
deformity
Q 17.4, Q 18.8, Birth
Umbilical hernia & polydactyly Q 74.9 6 weeks’ visit
Umbilical hernia & nodular swelling
left frontotemporal
K 42, Q 69.9 6 weeks’ visit
K 42, Q 82.9,
Q 55.6, Q 82.5
Musculoskeletal 101 56 Umbilical hernia (64) K 42 6 weeks’ visit
Umbilical hernia & inguinal hernia
(1)
K 42, K40 6 weeks’ visit
Inguinal hernia (2) K 40 6 weeks’ visit
Polydactyly (26) Q 69 Birth/6 weeks’ visit
Genu recurvatum (1) Q 68.2 Birth
Congenital club foot (4) Q 66.0 Birth/6 weeks’ visit
Brachymetatarsia (1) Q 74.8 6 weeks’ visit
Syndactyly (webbed toes) (1) Q 70.3 Birth
Unspeciﬁed lower limb deformity
(1)
Q 74.9 6 weeks’ visit
Central nervous
system
32 Anencephaly Q 00.0 Birth
Hydrocephalus Q 03.9 Birth
Spinal biﬁda (meningomyelocele &
hydrocephalus)
Q 05.2 Birth
Skin 38 21 Birth mark (37) Q.82.5 Birth/6 weeks’ visit
Poliosis (1) Q.84.0 Birth
Unspeciﬁed 1 1 Unspeciﬁed anomaly of the
cardiorespiratory system
Q.34.9 Birth
Total 180 100 ICD-10
aMajor anomalies are highlighted in bold; multiple system anomalies that included at least one major anomaly were also classiﬁed as
major anomalies.
bAnomalies were detected at birth by a midwife, and detected at 6 weeks’ or at an illness visit by a study physician. ICD, Interna-
tional Classiﬁcation of Diseases Codes; Version 10; GIT, gastrointestinal tract; VSD, ventricular septal defect;
860 NDIBAZZA ET AL.
Birth Defects Research (Part A) 91:857861 (2011)anomalies in the population. Midwives are usually respon-
sible for care both at delivery and at the 6-week postnatal
visit, and would be able to identify overt congenital anoma-
lies but could miss the subtle ones. Sensitization of mid-
wives to the importance of documenting congenital anoma-
lies would improve surveillance for these conditions. Train-
ing health professionals to recognize birth defects before
hospital discharge would minimize the underestimation of
congenital anomalies in this population. Moreover, the
introduction of advanced techniques such as fetal visualiza-
tion using ultrasound screening and chromosome microar-
ray testing at birth, would greatly improve the early detec-
tion of anomalies in many developing countries.
Underreporting in our study would have resulted from
enrollment of pregnant women in the second and third
trimester and exclusion if they had an abnormal preg-
nancy, a lack of postmortem examination of stillborn
infants, and those delivered at home who died in the
neonatal period, incomplete follow-up to age one year,
and lack of genetic studies for genetic and syndromic
defects, or of the hemoglobinopathies; all of these may
have resulted in an underestimation of the overall preva-
lence of congenital anomalies. However, our study pro-
vides a fair representation of data on congenital anoma-
lies in a typical African population.
CONCLUSION
Even as extensive literature is available on congenital
anomalies in the developing world, there is a dismal
scarcity of comparable data from Sub-Saharan Africa. As
developing countries continue to see a decline in child-
hood infectious diseases, congenital anomalies will take
on a greater signiﬁcance as a cause of morbidity and
mortality. Training of midwives in surveillance for con-
genital anomalies and their management should be
encouraged for appropriate prevention, management,
and health care planning.
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